AU4307396A - Kit for osteoporosis treatment cycle - Google Patents
Kit for osteoporosis treatment cycle Download PDFInfo
- Publication number
- AU4307396A AU4307396A AU43073/96A AU4307396A AU4307396A AU 4307396 A AU4307396 A AU 4307396A AU 43073/96 A AU43073/96 A AU 43073/96A AU 4307396 A AU4307396 A AU 4307396A AU 4307396 A AU4307396 A AU 4307396A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutically acceptable
- tiludronic acid
- calcium
- kit
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9414630A FR2727629A1 (fr) | 1994-12-06 | 1994-12-06 | Trousse pour cycle de traitement de l'osteoporose |
| FR9414630 | 1994-12-06 | ||
| PCT/FR1995/001596 WO1996017616A1 (fr) | 1994-12-06 | 1995-12-05 | Trousse pour cycle de traitement de l'osteoporose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4307396A true AU4307396A (en) | 1996-06-26 |
Family
ID=9469504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU43073/96A Abandoned AU4307396A (en) | 1994-12-06 | 1995-12-05 | Kit for osteoporosis treatment cycle |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0797444A1 (fr) |
| JP (1) | JPH10509729A (fr) |
| KR (1) | KR980700083A (fr) |
| CN (1) | CN1168634A (fr) |
| AR (1) | AR002946A1 (fr) |
| AU (1) | AU4307396A (fr) |
| BR (1) | BR9509961A (fr) |
| CA (1) | CA2207028A1 (fr) |
| CZ (1) | CZ175397A3 (fr) |
| FI (1) | FI972383A (fr) |
| FR (1) | FR2727629A1 (fr) |
| HU (1) | HUT77382A (fr) |
| IL (1) | IL116168A0 (fr) |
| MA (1) | MA23737A1 (fr) |
| NO (1) | NO972558L (fr) |
| PL (1) | PL320564A1 (fr) |
| SK (1) | SK68597A3 (fr) |
| TR (1) | TR199501530A1 (fr) |
| WO (1) | WO1996017616A1 (fr) |
| ZA (1) | ZA9510184B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| BR0308901A (pt) | 2002-05-10 | 2005-01-04 | Hoffmann La Roche | ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose |
| SI1596870T2 (sl) * | 2002-12-20 | 2011-07-29 | Hoffmann La Roche | Formulacija z visokim odmerkom ibandronata |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587956T2 (de) * | 1984-04-30 | 1995-05-24 | Procter & Gamble | Ausrüstung für die Verwendung bei der Behandlung von Osteoporose. |
| US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
| AU659329B2 (en) * | 1992-06-30 | 1995-05-11 | Procter & Gamble Pharmaceuticals, Inc. | Use of phosphonates for the treatment of osteoporosis |
| FR2694558B1 (fr) * | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant. |
-
1994
- 1994-12-06 FR FR9414630A patent/FR2727629A1/fr active Granted
-
1995
- 1995-11-28 IL IL11616895A patent/IL116168A0/xx unknown
- 1995-11-30 ZA ZA9510184A patent/ZA9510184B/xx unknown
- 1995-12-04 MA MA24086A patent/MA23737A1/fr unknown
- 1995-12-04 TR TR95/01530A patent/TR199501530A1/xx unknown
- 1995-12-05 CZ CZ971753A patent/CZ175397A3/cs unknown
- 1995-12-05 JP JP8517359A patent/JPH10509729A/ja not_active Ceased
- 1995-12-05 BR BR9509961A patent/BR9509961A/pt not_active Application Discontinuation
- 1995-12-05 PL PL95320564A patent/PL320564A1/xx unknown
- 1995-12-05 WO PCT/FR1995/001596 patent/WO1996017616A1/fr not_active Application Discontinuation
- 1995-12-05 SK SK685-97A patent/SK68597A3/sk unknown
- 1995-12-05 AR ARP950100438A patent/AR002946A1/es unknown
- 1995-12-05 KR KR1019970703784A patent/KR980700083A/ko not_active Application Discontinuation
- 1995-12-05 AU AU43073/96A patent/AU4307396A/en not_active Abandoned
- 1995-12-05 CN CN95196670A patent/CN1168634A/zh active Pending
- 1995-12-05 CA CA002207028A patent/CA2207028A1/fr not_active Abandoned
- 1995-12-05 EP EP95941761A patent/EP0797444A1/fr not_active Withdrawn
- 1995-12-05 HU HU9702097A patent/HUT77382A/hu unknown
-
1997
- 1997-06-05 FI FI972383A patent/FI972383A/fi not_active Application Discontinuation
- 1997-06-05 NO NO972558A patent/NO972558L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI972383A0 (fi) | 1997-06-05 |
| NO972558L (no) | 1997-08-05 |
| PL320564A1 (en) | 1997-10-13 |
| JPH10509729A (ja) | 1998-09-22 |
| KR980700083A (ko) | 1998-03-30 |
| WO1996017616A1 (fr) | 1996-06-13 |
| ZA9510184B (en) | 1996-06-11 |
| TR199501530A1 (tr) | 1996-10-21 |
| HUT77382A (hu) | 1998-04-28 |
| CA2207028A1 (fr) | 1996-06-13 |
| BR9509961A (pt) | 1997-11-25 |
| FI972383A (fi) | 1997-06-05 |
| SK68597A3 (en) | 1997-11-05 |
| CN1168634A (zh) | 1997-12-24 |
| CZ175397A3 (en) | 1997-10-15 |
| AR002946A1 (es) | 1998-05-27 |
| FR2727629B1 (fr) | 1997-02-28 |
| FR2727629A1 (fr) | 1996-06-07 |
| EP0797444A1 (fr) | 1997-10-01 |
| NO972558D0 (no) | 1997-06-05 |
| MX9704105A (es) | 1997-09-30 |
| MA23737A1 (fr) | 1996-07-01 |
| IL116168A0 (en) | 1996-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050026871A1 (en) | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative | |
| US20050214388A1 (en) | Multivitamin formulations containing controlled-release magnesium | |
| US4861590A (en) | Sustained release fluoride and calcium composition | |
| CA2454200A1 (fr) | Formes posologiques pour la liberation gastrique immediate d'un stimulateur de transport du calcium et la liberation gastrique retardee d'un bis-phosphonate | |
| DE69837450T2 (de) | Alendronate zur Behandlung von Osteoporose | |
| KR100263284B1 (ko) | 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하는 생체 이용률이 개선된 정제 | |
| JP2006514695A (ja) | ビタミンｄ誘導体の前用量投与によってアレンドロネート又は他のビスフォスフォネートの全体利用効率を高める方法 | |
| US20170157001A1 (en) | Compositions Comprising Strontium and Uses Thereof in the Treatment or Prevention of Gingivitis, Periodontitis, Periodontitis as a Manifestation of Systemic Diseases, and Necrotizing Periodontal Diseases | |
| US4859467A (en) | Sustained release fluoride composition | |
| US5013728A (en) | Composition for treating osteoporosis and hormonal imbalance | |
| CA2671727C (fr) | Composition contenant un acide bisphosphonique combine a de la vitamine d | |
| CZ219798A3 (cs) | Prostředek pro prevenci a léčbu osteoporézy | |
| AU4307396A (en) | Kit for osteoporosis treatment cycle | |
| US5286490A (en) | Transdermal fluoride medication | |
| MXPA97004105A (en) | Set for use in a therapeutic treatment cycle of osteoporo | |
| CA2219354A1 (fr) | Prevention des pertes de dnets par l'administration d'alendronate ou de ses sels | |
| HU211084B (en) | Process for producing oral pharmaceutical composition of bone strengthening activity | |
| EP0268868A2 (fr) | Compositions pharmaceutiques pour le traitement des maladies gastro-intestinales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |